These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Crystal structure of cancer chemopreventive Bowman-Birk inhibitor in ternary complex with bovine trypsin at 2.3 A resolution. Structural basis of Janus-faced serine protease inhibitor specificity. Koepke J; Ermler U; Warkentin E; Wenzl G; Flecker P J Mol Biol; 2000 May; 298(3):477-91. PubMed ID: 10772864 [TBL] [Abstract][Full Text] [Related]
23. Molecular mechanism of enzyme inhibition: prediction of the three-dimensional structure of the dimeric trypsin inhibitor from Leucaena leucocephala by homology modelling. Sattar R; Ali SA; Kamal M; Khan AA; Abbasi A Biochem Biophys Res Commun; 2004 Feb; 314(3):755-65. PubMed ID: 14741700 [TBL] [Abstract][Full Text] [Related]
24. Squash trypsin inhibitors from Momordica cochinchinensis exhibit an atypical macrocyclic structure. Hernandez JF; Gagnon J; Chiche L; Nguyen TM; Andrieu JP; Heitz A; Trinh Hong T; Pham TT; Le Nguyen D Biochemistry; 2000 May; 39(19):5722-30. PubMed ID: 10801322 [TBL] [Abstract][Full Text] [Related]
25. Demonstration that 1-trans-epoxysuccinyl-L-leucylamido-(4-guanidino) butane (E-64) is one of the most effective low Mr inhibitors of trypsin-catalysed hydrolysis. Characterization by kinetic analysis and by energy minimization and molecular dynamics simulation of the E-64-beta-trypsin complex. Sreedharan SK; Verma C; Caves LS; Brocklehurst SM; Gharbia SE; Shah HN; Brocklehurst K Biochem J; 1996 Jun; 316 ( Pt 3)(Pt 3):777-86. PubMed ID: 8670152 [TBL] [Abstract][Full Text] [Related]
26. Crystal structure of trypsin-turkey egg white inhibitor complex. Ibrahim BS; Pattabhi V Biochem Biophys Res Commun; 2004 Jan; 313(1):8-16. PubMed ID: 14672690 [TBL] [Abstract][Full Text] [Related]
27. Structure of the Kunitz-type soybean trypsin inhibitor (STI): implication for the interactions between members of the STI family and tissue-plasminogen activator. De Meester P; Brick P; Lloyd LF; Blow DM; Onesti S Acta Crystallogr D Biol Crystallogr; 1998 Jul; 54(Pt 4):589-97. PubMed ID: 9761854 [TBL] [Abstract][Full Text] [Related]
28. Engineering trypsin for inhibitor resistance. Batt AR; St Germain CP; Gokey T; Guliaev AB; Baird T Protein Sci; 2015 Sep; 24(9):1463-74. PubMed ID: 26106067 [TBL] [Abstract][Full Text] [Related]
29. Solution conformations of the gamma-carboxyglutamic acid domain of bovine prothrombin fragment 1, residues 1-65. Charifson PS; Darden T; Tulinsky A; Hughey JL; Hiskey RG; Pedersen LG Proc Natl Acad Sci U S A; 1991 Jan; 88(2):424-8. PubMed ID: 1988943 [TBL] [Abstract][Full Text] [Related]
30. Graph-representation of oxidative folding pathways. Agoston V; Cemazar M; Kaján L; Pongor S BMC Bioinformatics; 2005 Jan; 6():19. PubMed ID: 15676070 [TBL] [Abstract][Full Text] [Related]
31. Distance between the basic group of the amino acid residue's side chain in position P1 of trypsin inhibitor CMTI-III and Asp189 in the substrate pocket of trypsin has an essential influence on the inhibitory activity. Jaśkiewicz A; Lesner A; Rózycki J; Rodziewicz S; Rolka K; Ragnarsson U; Kupryszewski G Biochem Biophys Res Commun; 1997 Nov; 240(3):869-71. PubMed ID: 9398660 [TBL] [Abstract][Full Text] [Related]
32. Crystal structure reveals basis for the inhibitor resistance of human brain trypsin. Katona G; Berglund GI; Hajdu J; Gráf L; Szilágyi L J Mol Biol; 2002 Feb; 315(5):1209-18. PubMed ID: 11827488 [TBL] [Abstract][Full Text] [Related]
33. Structural model of a synthetic Ca2+ channel with bound Ca2+ ions and dihydropyridine ligand. Zhorov BS; Ananthanarayanan VS Biophys J; 1996 Jan; 70(1):22-37. PubMed ID: 8770184 [TBL] [Abstract][Full Text] [Related]
34. Characterization and 2D NMR study of the stable [9-21, 15-27] 2 disulfide intermediate in the folding of the 3 disulfide trypsin inhibitor EETI II. Le-Nguyen D; Heitz A; Chiche L; el Hajji M; Castro B Protein Sci; 1993 Feb; 2(2):165-74. PubMed ID: 8443596 [TBL] [Abstract][Full Text] [Related]
35. Local structure due to an aromatic-amide interaction observed by 1H-nuclear magnetic resonance spectroscopy in peptides related to the N terminus of bovine pancreatic trypsin inhibitor. Kemmink J; van Mierlo CP; Scheek RM; Creighton TE J Mol Biol; 1993 Mar; 230(1):312-22. PubMed ID: 7680725 [TBL] [Abstract][Full Text] [Related]
36. Conformations of the third hypervariable region in the VH domain of immunoglobulins. Morea V; Tramontano A; Rustici M; Chothia C; Lesk AM J Mol Biol; 1998 Jan; 275(2):269-94. PubMed ID: 9466909 [TBL] [Abstract][Full Text] [Related]
37. The structure of a Michaelis serpin-protease complex. Ye S; Cech AL; Belmares R; Bergstrom RC; Tong Y; Corey DR; Kanost MR; Goldsmith EJ Nat Struct Biol; 2001 Nov; 8(11):979-83. PubMed ID: 11685246 [TBL] [Abstract][Full Text] [Related]